You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: July 18, 2024

MINOCIN Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Minocin patents expire, and what generic alternatives are available?

Minocin is a drug marketed by Bausch, Triax Pharms, Lederle, and Rempex. and is included in five NDAs. There are three patents protecting this drug and one Paragraph IV challenge.

This drug has thirty patent family members in twenty-two countries.

The generic ingredient in MINOCIN is minocycline hydrochloride. There are fifteen drug master file entries for this compound. Thirty-four suppliers are listed for this compound. Additional details are available on the minocycline hydrochloride profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Minocin

A generic version of MINOCIN was approved as minocycline hydrochloride by WATSON LABS on December 30th, 1991.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for MINOCIN?
  • What are the global sales for MINOCIN?
  • What is Average Wholesale Price for MINOCIN?
Summary for MINOCIN
Drug patent expirations by year for MINOCIN
Drug Prices for MINOCIN

See drug prices for MINOCIN

Drug Sales Revenue Trends for MINOCIN

See drug sales revenues for MINOCIN

Recent Clinical Trials for MINOCIN

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Baystate Medical CenterPhase 2
Children's Hospital Medical Center, CincinnatiPhase 1
Sun Yat-sen UniversityPhase 2

See all MINOCIN clinical trials

Pharmacology for MINOCIN
Paragraph IV (Patent) Challenges for MINOCIN
Tradename Dosage Ingredient Strength NDA ANDAs Submitted Submissiondate
MINOCIN Injection minocycline hydrochloride 100 mg/vial 050444 1 2020-10-16

US Patents and Regulatory Information for MINOCIN

MINOCIN is protected by three US patents.

Patents protecting MINOCIN


Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up

Tetracycline compositions
Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up
Patented Use: METHOD OF TREATING BACTERIAL INFECTIONS

Tetracycline compositions
Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up
Patented Use: METHOD OF TREATING BACTERIAL INFECTIONS

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bausch MINOCIN minocycline hydrochloride CAPSULE;ORAL 050649-001 May 31, 1990 AB RX Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Rempex MINOCIN minocycline hydrochloride INJECTABLE;INJECTION 050444-001 Approved Prior to Jan 1, 1982 RX Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Triax Pharms MINOCIN minocycline hydrochloride CAPSULE;ORAL 050315-002 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Rempex MINOCIN minocycline hydrochloride INJECTABLE;INJECTION 050444-001 Approved Prior to Jan 1, 1982 RX Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Bausch MINOCIN minocycline hydrochloride CAPSULE;ORAL 050649-003 Feb 12, 2001 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

International Patents for MINOCIN

See the table below for patents covering MINOCIN around the world.

Country Patent Number Title Estimated Expiration
Mexico 347919 COMPOSICIONES DE TETRACICLINA. (TETRACYCLINE COMPOSITIONS.) ⤷  Sign Up
Hong Kong 1180586 四環素組合物 (TETRACYCLINE COMPOSITIONS) ⤷  Sign Up
China 102970992 Tetracycline compositions ⤷  Sign Up
Brazil 112012028524 composições farmacêuticas, respectivos usos e métodos de preparação, composição sólida solúvel em água e kits ⤷  Sign Up
Singapore 185513 TETRACYCLINE COMPOSITIONS ⤷  Sign Up
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.